Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Treasury Shares (2024 - 2025)

Janux Therapeutics has reported Treasury Shares over the past 2 years, most recently at $704869.0 for Q4 2025.

  • Quarterly Treasury Shares rose 106.19% to $704869.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $704869.0 through Dec 2025, up 106.19% year-over-year, with the annual reading at $704869.0 for FY2025, 106.19% up from the prior year.
  • Treasury Shares was $704869.0 for Q4 2025 at Janux Therapeutics, up from $699467.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $704869.0 in Q4 2025 and troughed at $17500.0 in Q2 2024.